Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat

Transplantation

Volumn 71, Issue 8, 2001, Pages 1124-1131

  Saiho, K O ^a   Jager, Mark D ^b   Tsui, Tung Y U ^a   Deiwick, Andrea ^a   Dinkel, Astrid ^a   Rohde, Frank ^a   Dahlke, Marc H ^b   Lauth, Oliver ^a   Wonigeit, Kurt ^a   Schlitt, Hans J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; FAS LIGAND; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD45; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLOGRAFT; SURVIVAL TIME; T LYMPHOCYTE;

EID: 0035034227     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200104270-00020     Document Type: Article

References (34)

1. Ortho Multicentre Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for the rejection of cadaveric renal transplants. N Engl J Med 1985; 313: 337.
2. Nelson PW, Cosimi AB, Delmonica FL, et al. Anti-thymocyte globulin as the primary treatment for renal allograft rejection. Transplantation 1983; 36: 587.
3. Soulillou JP, Cantarovich D, LeMauff B, et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor monoclonal antibody (33B3.1) as compared with rabbit anti-thymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990; 332: 1175.
4. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP for the CHIB 201 International Study Group. Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997; 350: 1193.
5. Thomas M. The leukocyte common antigen family. Annu Rev Immunol 1989; 7: 339.
6. Woodruff MFA, Anderson NA. Effect of lymphocyte depletion by thoracic duct fistula and administration of anti-lymphocytic serum on the survival of skin homografts in rats. Nature 1963; 200: 702.
7. Fabre JW, Sunderland CA, Williams AF. Immunosuppressive properties of rabbit antibodies against a major glycoprotein restricted to rat leukocyte membranes. Transplantation 1980; 30: 167.
8. Lazarovits AI, Poppema S, Zhang Z, et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996; 380: 717.
9. Ko S, Deiwick A, Jäger MD, et al. The functional relevance of passenger leukocytes and microchimerism for tolerance induction to allogeneic heart grafts in a rat model. Nat Med 1999; 5: 1292.
10. Schwinzer R, Hedrich HJ, Wonigeit K. T cell differentiation in athymic nude rats (rnu/rnu): demonstration of a distorted T cell subset structure by flow cytometry analysis. Eur J Immunol 1989; 19: 1841.
11. Huffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 1990; 145: 2220.
12. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
13. Wang J, Nonomura N, Ichimaru N, et al. Expression of Fas and Fas ligand in renal grafts with acute and chronic rejection in the rat model. J Interferon Cytokine Res 1997; 17: 369.
14. Siebert PD, Larrick JW. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 1993; 14: 244.
15. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 1994; 177: 23.
16. Wonigeit K. Definition of lymphocyte antigens in rats: RT-Ly-1, RT-Ly-2, and a new MHC-linked antigen system. Transplant Proc 1979; 11:1334.
17. Lubaroff DM, Butcher G, DeWitt C, et al. Standardized nomenclature for the rat T-cell alloantigens: report of the committee. Transplant Proc 1983; 15: 1683.
18. Péguet-Navarro J, Dalbiez-Gauthier C, Dezutter-Dambuyant C, Schmitt D. Dissection of Langhans cells' allostimulatory function: the need for an activation step for full development of accessory function. Eur J Immunol 1993; 23: 376.
19. Kamada N, Shinomiya T. Serology of liver transplantation in the rat. Transplantation 1986; 42: 7.
20. Fechner JH Jr , Vargo DJ, Geissler EK, et al. Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Transplantation 1997; 63: 1339.
21. Dahmen U, Qian S, Rao AS, et al. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 1994; 58: 1.
22. Burlingham WJ, Grailer AP, Fechner JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation. 1995; 59: 1147.
23. Thomas JM, Carver M, Cunningham P, Sash C, Park K, Thomas F. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. Transplantation 1989; 47: 209.
24. Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen 0. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell Immunol 1997; 181: 93.
25. Yahata T, Abe N, Yahata G, et al. The essential role of phorbol estersensitive protein kinase C isoforms in activation-induced cell death of Thl cells. Eur J Immunol 1999; 29: 727.
26. Sata M, Walsh K. TNFa regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med 1998; 4: 415.
27. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
28. Armstrong N, Buckley P, Oberley T, et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 1998; 66: 5.
29. Knechtle SJ, Fechner JH Jr, Dong Y, et al. Primate renal transplants using immunotoxin. Surgery 1998; 124: 438.
30. Thomas JM, Neville DM, Contreras JL, et al. Preclinical studies of allo-graft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. Transplantation 1997; 64: 124
31. Calne R, Moffatt SD, Friend PJ, et al. Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999; 68: 1613.
32. Hale G, Clark MR, Marcus R, et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH 1H. Lancet 1988; 2: 1394.
33. Calne R, Friend P, Mofiatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporine monotherapy in renal allograft recipients. Lancet 1998; 351: 1701.
34. Thomas JM, Contreras JL, JiangXL, et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999; 68:1660.